| |
 |
|
Class Information
Number: 435/325
Name: Chemistry: molecular biology and microbiology > Animal cell, per se (e.g., cell lines, etc.); composition thereof; process of propagating, maintaining or preserving an animal cell or composition thereof; process of isolating or separating an animal cell or composition thereof; process of preparing a composition containing an animal cell; culture media therefore
Description: Subject matter including animal cells, per se; compositions containing animal cells; processes of in vitro propagation of animal cells or groups of cells that are not organized tissues; processes of maintaining or preserving animal cells or compositions thereof; processes of isolating or separating an animal cell or composition thereof; processes of preparing a composition containing animal cells; culture media therefore.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 435/326 |
Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof |
634 |
| 435/349 |
Avian cell, per se |
116 |
| 435/350 |
Canine cell, per se |
90 |
| 435/404 |
Culture medium, per se |
248 |
| 435/351 |
Feline cell, per se |
43 |
| 435/346 |
Fused or hybrid cell, per se |
235 |
| 435/348 |
Insect cell, per se |
619 |
| 435/373 |
Method of co-culturing cells |
280 |
| 435/383 |
Method of culturing cells in suspension |
275 |
| 435/382 |
Method of culturing encapsulated cells |
149 |
| 435/378 |
Method of detaching cells, digesting tissue or establishing a primary culture |
224 |
| 435/375 |
Method of regulating cell metabolism or physiology |
1,536 |
| 435/374 |
Method of storing cells in a viable state |
217 |
| 435/363 |
Primate cell, per se |
204 |
| 435/352 |
Rodent cell, per se |
236 |
| 435/395 |
Solid support and method of culturing cells on said solid support |
540 |
| 435/347 |
Two or more cell types, per se, in co-culture |
108 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618943 |
Fusion polypeptides, and use thereof in antivascular tumor therapy |
Nov. 17, 2009 |
| 7618818 |
Method for detecting leptin receptor ligands |
Nov. 17, 2009 |
| 7618817 |
Genetically modified human natural killer cell lines |
Nov. 17, 2009 |
| 7618786 |
Method for identifying modulators of human orexin-2 receptor |
Nov. 17, 2009 |
| 7618775 |
Expanding the eukaryotic genetic code |
Nov. 17, 2009 |
| 7618770 |
Methods and apparatus for reducing protein content in sperm cell extenders |
Nov. 17, 2009 |
| 7618622 |
Treatment of Parkinson's disease and related disorders using postpartum derived cells |
Nov. 17, 2009 |
| 7618621 |
Mammalian multipotent neural stem cells and compositions, methods of preparation and methods of administration thereof |
Nov. 17, 2009 |
| 7618452 |
Artificially produced, three-dimensional muscle tissue |
Nov. 17, 2009 |
| 7615676 |
Transgenic screen and method for screening modulators of brain-derived neurotrophic factor (BDNF) production |
Nov. 10, 2009 |
| 7615374 |
Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions |
Nov. 10, 2009 |
| 7612250 |
Nuclear transfer embryo formation method |
Nov. 3, 2009 |
| 7612190 |
Method for targeting a polypeptide onto cellular surface |
Nov. 3, 2009 |
| 7612185 |
Nucleic acid biosensors |
Nov. 3, 2009 |
| 7612167 |
Human hematopoietic growth regulatory gene product |
Nov. 3, 2009 |
| 7611868 |
Recombinant modified adenovirus fiber protein |
Nov. 3, 2009 |
| 7611865 |
Polynucleotides encoding truncated glial cell line-derived neurotrophic factor |
Nov. 3, 2009 |
| 7611857 |
IL-receptor like molecules and uses thereof |
Nov. 3, 2009 |
| 7608707 |
siRNA targeting survivin |
Oct. 27, 2009 |
| 7608706 |
siRNA targeting ras-related nuclear protein |
Oct. 27, 2009 |
| 7608705 |
Oligonucleotides, agents containing these oligonucleotides, and the use thereof |
Oct. 27, 2009 |
| 7608704 |
Secreted proteins |
Oct. 27, 2009 |
| 7608698 |
Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
Oct. 27, 2009 |
| 7608454 |
Vascularization enhanced graft constructs |
Oct. 27, 2009 |
| 7608452 |
Polynucleotides encoding cytokine receptor zcytor19 |
Oct. 27, 2009 |
| 7608431 |
Fed-batch process for production of erythropoietin in human embryonic retina cells that express adenovirus E1A |
Oct. 27, 2009 |
| 7608430 |
Interferon-.gamma. antagonists and therapeutic uses thereof |
Oct. 27, 2009 |
| 7608428 |
Polynucleotide encoding an IL-28B polypeptide |
Oct. 27, 2009 |
| 7608427 |
Polynucleotide encoding an IL-28B polypeptide |
Oct. 27, 2009 |
| 7608425 |
Methods for protein expression in mammalian cells in serum-free medium |
Oct. 27, 2009 |
| 7608423 |
Expanding the eukaryotic genetic code |
Oct. 27, 2009 |
| 7608422 |
Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhibitory/instability regions |
Oct. 27, 2009 |
| 7604991 |
Method of generating islet beta-cells from exocrine pancreatic cells |
Oct. 20, 2009 |
| 7604990 |
Methods of regulating differentiation in stem cells |
Oct. 20, 2009 |
| 7604989 |
Inhibition of apoptosis process and improvement of cell performance |
Oct. 20, 2009 |
| 7604934 |
Method of screening candidate compounds for susceptibility to biliary excretion by endogenous transport systems |
Oct. 20, 2009 |
| 7604933 |
Method for sorting tumor cells |
Oct. 20, 2009 |
| 7601885 |
Transgenic plant comprising a cassava vein mosaic virus promoter and a heterologous nucleic acid sequence |
Oct. 13, 2009 |
| 7601826 |
Genes and polypeptides relating to human pancreatic cancers |
Oct. 13, 2009 |
| 7601825 |
Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer |
Oct. 13, 2009 |
| 7601812 |
Immunomodulating agents from parasitic worms and method for isolation thereof |
Oct. 13, 2009 |
| 7601807 |
Protease, DNA encoding the same, and method for manufacturing protease |
Oct. 13, 2009 |
| 7601805 |
Photoprotein with improved bioluminescence |
Oct. 13, 2009 |
| 7601699 |
Production of reprogrammed cells with restored potential |
Oct. 13, 2009 |
| 7601687 |
Mechanism for identifying drugs for the treatment of type II diabetes |
Oct. 13, 2009 |
| 7601533 |
Reverse two-hybrid systems |
Oct. 13, 2009 |
| 7601518 |
Secretion of neublastin |
Oct. 13, 2009 |
| 7601516 |
Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility |
Oct. 13, 2009 |
| 7601514 |
Nucleic acid encoding PRO10268 polypeptides |
Oct. 13, 2009 |
| 7601501 |
Controlling osteogenesis by inhibition of osteogenic suppressors |
Oct. 13, 2009 |
|
|
|
